Score Pharma, Inc. focuses on developing innovative therapeutic solutions that leverage advanced biopharmaceutical technologies. The company specializes in the creation of novel drug formulations and delivery systems aimed at enhancing the efficacy and safety of existing medications. Their pipeline includes a range of products designed to address unmet medical needs, utilizing cutting-edge research in pharmacology and drug development to optimize therapeutic outcomes.

In addition to their drug development efforts, Score Pharma emphasizes the importance of scientific research and collaboration in advancing their technologies. The company employs a multidisciplinary approach, integrating insights from various fields such as molecular biology and chemistry to drive innovation. This commitment to scientific excellence enables Score Pharma to explore new avenues for treatment and improve patient care through their proprietary technologies and products.

United States

Score Pharma is developing new, more potent antibody therapeutics by transforming existing clinically proven antibody therapeutics for an improved patient response. 

Our team is prioritizing cancer therapies such as non-Hodgkin lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL), and HER2-positive breast cancer. 

By enhancing existing technologies with a patent-pending improvement process, we expect better therapies with a higher probability of clinical and regulatory success.

Score Pharma, Inc.

Company Details